Home/Filings/4/0000899243-22-004836
4//SEC Filing

BRYCE RICHARD PAUL 4

Accession 0000899243-22-004836

CIK 0001724979other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:40 PM ET

Size

5.6 KB

Accession

0000899243-22-004836

Insider Transaction Report

Form 4
Period: 2022-01-07
BRYCE RICHARD PAUL
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-07+53,06453,064 total
    Exercise: $12.01Exp: 2032-01-07Common Stock (53,064 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 53,064 shares of the Issuer's common stock, one quarter of which will vest on January 7, 2023, with the remaining three quarters vesting in equal monthly installments through January 7, 2026, subject to the Reporting Person's continued service to the Issuer.

Issuer

Rain Therapeutics Inc.

CIK 0001724979

Entity typeother

Related Parties

1
  • filerCIK 0001553037

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:40 PM ET
Size
5.6 KB